journal
Journals ClinicoEconomics and Outcomes ...

ClinicoEconomics and Outcomes Research : CEOR

https://read.qxmd.com/read/38596283/cost-savings-associated-with-multi-disciplinary-team-approach-for-reducing-macrovascular-and-microvascular-complications-in-patients-with-type-2-diabetes-a-predictive-model
#1
JOURNAL ARTICLE
Abdulmajeed Alshowair, Saleh Altamimi, Faisal A Alruhaimi, Saad Alshahrani, Fatima Alsuwailem, Mona Alkhaldi, Haiam Abdalla, Fahad Hamad Alkhuraiji, Montaser Saad Alaqeel, Salman Sulaiman Almureef, Salman Alhawasy, Amro Abdel-Azeem
PURPOSE: This study aims to predict the expected cost savings associated with implementing a multidisciplinary team (MDT) approach to reduce macrovascular and microvascular complications among patients with type 2 diabetes mellitus (T2DM). METHODS: This economic evaluation study was conducted in Riyadh First Health Cluster, Saudi Arabia as a predictive model conceptualized by the authors based on models used in previous studies, particularly the CORE Diabetes Model...
2024: ClinicoEconomics and Outcomes Research: CEOR
https://read.qxmd.com/read/38584964/willingness-to-pay-for-social-health-insurance-among-health-care-professionals-in-north-wollo-zone-amhara-region-ethiopia-mixed-method-study-retraction
#2
(no author information available yet)
[This retracts the article DOI: 10.2147/CEOR.S421461.].
2024: ClinicoEconomics and Outcomes Research: CEOR
https://read.qxmd.com/read/38562567/key-performance-indicators-a-framework-for-allied-healthcare-educational-institutions
#3
REVIEW
Jithin Sreedharan, Arun Vijay Subbarayalu, Ajayan Kamalasanan, Ibrahim Albalawi, Gokul G Krishna, Ayedh Dhafer Alahmari, Jihad A Alsalamah, Mohammed G Alkhathami, Meshal Alenezi, Abdullah S Alqahtani, Mohammed Alahmari, Michael R Phillips, JoAnne MacDonald
BACKGROUND: Performance evaluation in the allied healthcare education sector is complex, making it essential for policymakers and managers to approach it comprehensively and thoughtfully to understand their performance. Hence, the development and monitoring of Key Performance Indicators (KPIs) in this domain must be considered one of the key priorities for the policymakers in AHIs. AIM: This study aims to develop a framework for the AHIs to extract and profile the indicators, measure, and report the results appropriately...
2024: ClinicoEconomics and Outcomes Research: CEOR
https://read.qxmd.com/read/38560410/racial-and-ethnic-differences-in-initiation-and-discontinuation-of-antiarrhythmic-medications-in-management-of-atrial-fibrillation
#4
JOURNAL ARTICLE
Ryan Kipp, Lee-Or Herzog, Rahul Khanna, Dongyu Zhang
BACKGROUND: Atrial fibrillation (AF) is associated with considerable morbidity and mortality. Timely management and treatment are critical in alleviating AF disease burden. There is significant heterogeneity in patterns of AF care. It is unclear whether there are racial and ethnic differences in treatment of AF following antiarrhythmic drug (AAD) prescription. METHODS: Using the Optum Clinformatics Data Mart-Socioeconomic Status database from January, 2009, through March, 2022, multivariable logistic regression techniques were used to examine the impact of race and ethnicity on rate of AAD initiation, as well as receipt of catheter ablation within two years of initiation...
2024: ClinicoEconomics and Outcomes Research: CEOR
https://read.qxmd.com/read/38560409/evaluating-health-expenditure-trends-and-disease-burden-in-india-a-cost-per-daly-approach
#5
JOURNAL ARTICLE
Bhavani Shankara Bagepally, Sajith Kumar S, Akhil Sasidharan
BACKGROUND: Efficient allocation of healthcare resources requires a comprehensive evaluation of healthcare spending and its impact on disease burden. This study aims to estimate the costs-per disability-adjusted life years (DALY) in India. Data from 2010 to 2019 on DALYs and health expenditure per capita (HEp) for individual states in India were utilised. DESIGN AND METHODS: We followed the CHEERS statement 2022 to present our study's methodology and outcomes. Pearson's product-moment correlations were used to analyse associations between DALYs and HEp...
2024: ClinicoEconomics and Outcomes Research: CEOR
https://read.qxmd.com/read/38505256/the-economic-burden-of-diabetic-retinopathy-in-jordan-cost-analysis-and-associated-factors
#6
JOURNAL ARTICLE
Rami A Al-Dwairi, Abdelwahab Aleshawi, Laith Abu-Zreig, Wafa Al-Shorman, Seren Al Beiruti, Ali Omar Alshami, Mohammed Z Allouh
OBJECTIVE: Diabetic retinopathy (DR) is the leading cause of visual loss worldwide in patients with diabetes mellitus (DM). The aims of our study are to describe the costs associated with (DR) and to evaluate its economic impact in Jordan. METHODS: Retrospectively, we included all patients with DM and classified them according to the severity of DR. Data regarding medical history, ophthalmic history, stage of DR, presence of DME, and the ophthalmic procedures and operations were collected...
2024: ClinicoEconomics and Outcomes Research: CEOR
https://read.qxmd.com/read/38495124/analysis-of-medicare-patients-treated-with-pimavanserin-versus-other-atypical-antipsychotics-a-cost-offset-model-evaluating-skilled-nursing-facility-stays-and-long-term-care-admissions-in-parkinson-s-disease-psychosis
#7
JOURNAL ARTICLE
Krithika Rajagopalan, Nazia Rashid, Vinod Yakkala, Dilesh Doshi
BACKGROUND: Patients with Parkinson's disease psychosis (PDP) treated with pimavanserin (PIM) versus other atypical antipsychotics (AAPs) including quetiapine (QUE) may have health-care cost savings due to fewer skilled nursing facility-stays (SNF-stays) and long-term care admissions (LTCA). METHODS: A decision analytic model was developed using the 2019 Medicare Patient Driven Payment Model (PDPM) to estimate SNF-stays and LTCA associated per-patient- per-year (PPPY) facility and rehabilitation costs among patients that initiated PIM vs QUE or vs other-AAPs (i...
2024: ClinicoEconomics and Outcomes Research: CEOR
https://read.qxmd.com/read/38476579/the-economic-impact-of-obesity-in-turkey-a-micro-costing-analysis
#8
JOURNAL ARTICLE
Dilek Gogas Yavuz, Omar Akhtar, Kaywei Low, Adrien Gras, Batu Gurser, Esra Safak Yilmaz, Amaury Basse
BACKGROUND: Turkey currently has the highest obesity prevalence among its European counterparts. 32% and 61% of the population live with obesity and overweight, respectively. Overweight and obesity are linked to non-communicable diseases that incur incremental health and economic costs. The significant public health concern warrants an assessment of the cost of obesity. METHODS: A micro-costing approach from the public payer perspective was conducted to estimate direct healthcare costs associated with ten obesity-related comorbidities (ORCs) in Turkey...
2024: ClinicoEconomics and Outcomes Research: CEOR
https://read.qxmd.com/read/38476578/medical-costs-associated-with-high-moderate-low-likelihood-of-adult-growth-hormone-deficiency-a-healthcare-claims-database-analysis
#9
JOURNAL ARTICLE
Kevin C J Yuen, Lewis S Blevins, David R Clemmons, Mads Faurby, Andrew R Hoffman, Nicky Kelepouris, Janice M Kerr, Jens Magelund Tarp, Maria Fleseriu
PURPOSE: Adult growth hormone deficiency (AGHD) is often underdiagnosed and undertreated, leading to costly comorbidities. Previously, we developed an algorithm to identify individuals in a commercially insured US population with high, moderate, or low likelihood of having AGHD. Here, we estimate and compare direct medical costs by likelihood level. PATIENTS AND METHODS: Retrospective, observational analysis using the Truven Health MarketScan database to analyze direct medical costs relating to inpatient and outpatient claims, outpatient prescription claims, medication usage, clinical utilization records, and healthcare expenditures...
2024: ClinicoEconomics and Outcomes Research: CEOR
https://read.qxmd.com/read/38463550/the-economic-burden-of-the-covid-19-pandemic-in-state-of-kuwait
#10
JOURNAL ARTICLE
Amrizal Muhammad Nur, Syed Mohamed Aljunid, Mohammad Almari
PURPOSE: The main aim of this study is to estimate the provider's cost, patients' cost (home and institutional quarantine cost) and the total economic burden of COVID-19 for patients with PCR positive in Kuwait. PATIENTS AND METHODS: This cross-sectional and retrospective study identified the cost incurred for treating COVID-19 inpatients admitted to a General Hospital in Kuwait, a designated COVID-19 treatment center by the Kuwait Government during pandemic. A total of 485 COVID-19 patients were randomly selected from May 1st to September 31st, 2021...
2024: ClinicoEconomics and Outcomes Research: CEOR
https://read.qxmd.com/read/38433888/challenges-with-estimating-long-term-overall-survival-in-extensive-stage-small-cell-lung-cancer-a-validation-based-case-study
#11
JOURNAL ARTICLE
Sukhvinder Johal, Lance Brannman, Victor Genestier, Hélène Cawston
OBJECTIVE: The study aimed to explore methods and highlight the challenges of extrapolating the overall survival (OS) of immunotherapy-based treatment in first-line extensive stage small-cell lung cancer (ES-SCLC). METHODS: Standard parametric survival models, spline models, landmark models, mixture and non-mixture cure models, and Markov models were fitted to 2-year data of the CASPIAN Phase 3 randomised trial of PD-L1 inhibitor durvalumab added to platinum-based chemotherapy (NCT03043872)...
2024: ClinicoEconomics and Outcomes Research: CEOR
https://read.qxmd.com/read/38374959/comparative-costs-to-medicare-and-medicare-beneficiaries-of-alternative-af-stroke-risk-reduction-strategies
#12
JOURNAL ARTICLE
Vivek Y Reddy, Yue Zhong, Alysha M McGovern, Stacey L Amorosi, Meghan B Gavaghan, Deanna S Hertz, Kaywei Low, Scott Freeman, David R Holmes
BACKGROUND: As healthcare costs are increasingly being shifted from payers to patients, it is important to understand the economic consequences of therapeutic strategies to both payers and patients. OBJECTIVE: To determine the relative costs to Medicare and Medicare beneficiaries (patients) of warfarin, non-vitamin K oral anticoagulants (NOACs), and left atrial appendage closure (LAAC) for stroke risk reduction in nonvalvular atrial fibrillation. METHODS: An economic model was developed to assess costs at 5 and 10 years...
2024: ClinicoEconomics and Outcomes Research: CEOR
https://read.qxmd.com/read/38352115/pharmacoeconomic-evaluation-of-costs-of-myelomeningocele-and-meningocele-treatment-and-screening
#13
REVIEW
Malvina Hoxha, Visar Malaj, Bruno Zappacosta, Najada Firza
BACKGROUND: The prevention of myelomeningocele (MMC) and meningocele (MC) is a public health concern. A systematic review on economic factors associated with MMC and MC can help the policy makers to evaluate the cost-effectiveness of screening and treatment. To our knowledge, this is the first systematic review to provide up-to date pharmacoeconomic evidence of all economic studies present in literature on different aspects of MMC and MC. METHODS: We searched in the National Health Service Economic Evaluation Database (NHSEED), PubMed, Cost-effectiveness Analysis Registry (CEA Registry), Centre for Reviews and Dissemination (CRD), Health Technology Assessment Database (HTAD), Cochrane Library, and Econlit...
2024: ClinicoEconomics and Outcomes Research: CEOR
https://read.qxmd.com/read/38348373/disutility-of-cognitive-processing-speed-cps-impairment-in-the-context-of-multiple-sclerosis-a-time-trade-off-tto-elicitation-study
#14
JOURNAL ARTICLE
Ralph H B Benedict, Pamela Vo, Nicholas Adlard, Olwyn Grennan, Ashley Enstone, Daisy Bridge, Robin Wyn, Stanley L Cohan
INTRODUCTION: Cognitive impairment, especially relating to cognitive processing speed, is a major cause of disability in people with multiple sclerosis (MS). Utility values are quantitative estimates of the quality of life experienced in specific health states and are a key component of cost-effectiveness modelling. However, existing health state utility values in MS typically focus on physical ability and are generally derived using generic (not disease-specific) measures of quality of life...
2024: ClinicoEconomics and Outcomes Research: CEOR
https://read.qxmd.com/read/38298908/methods-used-to-account-for-caregivers-sex-and-gender-within-studies-examining-the-financial-burden-of-caregivers-of-children-and-adolescents-results-from-a-scoping-review
#15
REVIEW
Jason Robert Guertin, Mahée Gilbert-Ouimet, Michèle Dugas, Valérie Carnovale, Laura Jalbert, Olha Svyntozelska, Juliette Demers, Léonie Matteau, Frédéric Bergeron, Annie LeBlanc
BACKGROUND: Interest in the financial burden of informal caregivers has been growing. Unfortunately, it remains unclear which method(s) should be used when quantifying this burden. PURPOSE: We conducted a scoping review aimed at identifying which methods have been used to conduct such work and quantified their performance. We were also interested in examining how sex and gender considerations were considered within selected studies. DATA SOURCES: Using a standardized approach, we identified studies published between 2012 and 2022 that aimed to document the financial burden of caregivers to child and adolescent patients...
2024: ClinicoEconomics and Outcomes Research: CEOR
https://read.qxmd.com/read/38293254/the-cost-effectiveness-of-dolutegravir-in-combination-with-tenofovir-and-lamivudine-for-hiv-therapy-a-systematic-review
#16
REVIEW
Santi Aprilianti, Auliasari M Utami, Auliya A Suwantika, Neily Zakiyah, Vanji Ikhsan Azis
The World Health Organization (WHO) recommends dolutegravir (DTG), a human immunodeficiency virus (HIV) medicine, as the first- and second-line treatment for all populations because, when compared to an efavirenz (EFV) regimen, plus two nucleoside reverse transcriptase inhibitors (NRTIs) has demonstrated significant effectiveness in HIV suppression in persons. This study aims to review evidence of the cost-effectiveness of DTG in combination with tenofovir and lamivudine compared with the standard of care for HIV therapy...
2024: ClinicoEconomics and Outcomes Research: CEOR
https://read.qxmd.com/read/38259876/budget-impact-analysis-of-minimally-invasive-versus-open-transforaminal-lumbar-interbody-fusion-for-lumbar-degenerative-disease-a-european-hospital-perspective
#17
JOURNAL ARTICLE
Roberto Bassani, Thibaut Galvain, Suzanne Battaglia, Hendramoorthy Maheswaran, George Wright, Ankita Kambli, Alessandra Piemontese
PURPOSE: When traditional therapies fail to provide relief from debilitating lower back pain, surgeries such as transforaminal lumbar interbody fusion (TLIF) may be required. This budget impact analysis (BIA) compared minimally-invasive (MI)-TLIF versus open (O)-TLIF for single-level fusion from an Italian hospital perspective. METHODS: The BIA compared costs of 100 MI-TLIF and 100 O-TLIF procedures from an Italian hospital perspective over a one-year time horizon...
2024: ClinicoEconomics and Outcomes Research: CEOR
https://read.qxmd.com/read/38235419/exploring-the-cost-utility-of-a-biomarker-predicting-persistent-severe-acute-kidney-injury-the-case-of-c-c-motif-chemokine-ligand-14-ccl14
#18
JOURNAL ARTICLE
Jorge Echeverri, Rui Martins, Kai Harenski, J Patrick Kampf, Paul McPherson, Julien Textoris, Jay L Koyner
BACKGROUND: Approximately 24% of hospitalized stage 2-3 acute kidney injury (AKI) patients will develop persistent severe AKI (PS-AKI), defined as KDIGO stage 3 AKI lasting ≥3 days or with death in ≤3 days or stage 2 or 3 AKI with dialysis in ≤3 days, leading to worse outcomes and higher costs. There is currently no consensus on an intervention that effectively reverts the course of AKI and prevents PS-AKI in the population with stage 2-3 AKI. This study explores the cost-utility of biomarkers predicting PS-AKI, under the assumption that such intervention exists by comparing C-C motif chemokine ligand 14 (CCL14) to hospital standard of care (SOC) alone...
2024: ClinicoEconomics and Outcomes Research: CEOR
https://read.qxmd.com/read/38274129/what-to-expect-in-2024-important-health-economics-and-outcomes-research-heor-trends
#19
EDITORIAL
Ivo Abraham, Mickael Hiligsmann, Kenneth K C Lee, Leslie Citrome, Giorgio Lorenzo Colombo, Mike Gregg
No abstract text is available yet for this article.
2023: ClinicoEconomics and Outcomes Research: CEOR
https://read.qxmd.com/read/38143783/the-cost-effectiveness-of-chin-tuck-against-resistance-compared-to-usual-care-in-citizens-with-oropharyngeal-dysphagia-an-economic-evaluation
#20
JOURNAL ARTICLE
Line Dyreborg, Sabine Michelsen Raunbak, Sabrina Storgaard Sørensen, Dorte Melgaard, Signe Westmark
PURPOSE: This study aims to evaluate the cost-effectiveness of chin tuck against resistance (CTAR) for citizens suffering from dysphagia compared to the standard municipal treatment in Denmark. PATIENTS AND METHODS: A cost-utility analysis, employing a municipal perspective, was conducted using cost data collected alongside clinical data of a randomized controlled trial evaluating the effect of CTAR training for citizens with dysphagia. The composition of the clinical randomized controlled trial, which included citizens with different diagnoses, means that participants had different disease courses...
2023: ClinicoEconomics and Outcomes Research: CEOR
journal
journal
43575
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.